在腺苷脱氨酶抑制剂存在的情况下，9-β-D-阿拉伯呋喃糖基腺嘌呤的毒性增加。 - Suppr | 超能文献

Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.

作者信息

Plunkett W, Cohen S S

出版信息

Ann N Y Acad Sci. 1977 Mar 4;284:91-102. doi: 10.1111/j.1749-6632.1977.tb21939.x.

DOI:10.1111/j.1749-6632.1977.tb21939.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.在腺苷脱氨酶抑制剂存在的情况下，9-β-D-阿拉伯呋喃糖基腺嘌呤的毒性增加。

Ann N Y Acad Sci. 1977 Mar 4;284:91-102. doi: 10.1111/j.1749-6632.1977.tb21939.x.

2

Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.两种提高腺嘌呤核苷类似物在动物细胞中活性的方法。

Cancer Res. 1975 Jun;35(6):1547-54.

3

Inhibition of adenosine deaminase to increase the antitumor activity of adenine nucleoside analogues.

Ann N Y Acad Sci. 1985;451:150-9. doi: 10.1111/j.1749-6632.1985.tb27106.x.

4

Toxicities of adenosine and 2'-deoxyadrenosine in L cells treated with inhibitors of adenosine deaminase.

Biochem Pharmacol. 1977 Jan 1;26(1):71-6. doi: 10.1016/0006-2952(77)90135-6.

5

Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).联合阿糖腺苷对腺苷脱氨酶的抑制作用及其对阿糖腺苷（阿糖胞苷）代谢处置的影响。

Ann N Y Acad Sci. 1977 Mar 4;284:9-20. doi: 10.1111/j.1749-6632.1977.tb21932.x.

6

Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.

Cancer Treat Rep. 1978 Mar;62(3):369-73.

7

Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.单独使用以及与9-β-D-阿拉伯呋喃糖基腺嘌呤联合使用赤藓红-9-(2-羟基-3-壬基)腺嘌呤治疗小鼠全身性疱疹病毒感染。

Antimicrob Agents Chemother. 1980 Oct;18(4):598-603. doi: 10.1128/AAC.18.4.598.

8

Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine.新型腺苷脱氨酶抑制剂异柯福霉素对间型霉素A和9-β-D-阿拉伯呋喃糖基腺嘌呤的毒性、抗肿瘤活性及组织分布的影响

J Antibiot (Tokyo). 1980 Mar;33(3):303-9. doi: 10.7164/antibiotics.33.303.

9

Synergistic effect of 3'-deoxyadenosine N1-oxide and adenosine deaminase inhibitors on growth of Ehrlich ascites tumor cells in vivo.3'-脱氧腺苷N1-氧化物与腺苷脱氨酶抑制剂对艾氏腹水瘤细胞体内生长的协同作用。

Cancer Chemother Pharmacol. 1988;21(1):35-9. doi: 10.1007/BF00262735.

10

Effect of adenosine deaminase inhibitors on the apparent rate of phosphorylation of deoxyadenosine.

Biochem Med. 1981 Jun;25(3):288-97. doi: 10.1016/0006-2944(81)90087-9.

引用本文的文献

1

5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine.5'-O-D-缬氨酰阿糖腺苷，一种用于提高抗病毒药物阿糖腺苷口服生物利用度的潜在前体药物。

Nucleosides Nucleotides Nucleic Acids. 2009;28(1):43-55. doi: 10.1080/15257770802581757.

2

Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.单独使用以及与9-β-D-阿拉伯呋喃糖基腺嘌呤联合使用赤藓红-9-(2-羟基-3-壬基)腺嘌呤治疗小鼠全身性疱疹病毒感染。

Antimicrob Agents Chemother. 1980 Oct;18(4):598-603. doi: 10.1128/AAC.18.4.598.